Abstract-Recently there has been growing evidence suggesting that beneficial effects of angiotensin-(1-7) ] in the heart are mediated by its receptor Mas. However, the signaling pathways involved in these effects in cardiomyocytes are unknown. Here, we investigated the involvement of the Ang-(1-7)/Mas axis in NO generation and Ca 2ϩ handling in adult ventricular myocytes using a combination of molecular biology, intracellular Ca 2ϩ imaging, and confocal microscopy. Acute Ang-(1-7) treatment (10 nmol/L) leads to NO production and activates endothelial NO synthase and Akt in cardiomyocytes. Ang-(1-7)-dependent NO raise was abolished by pretreatment with A-779 (1 mol/L). To confirm that Ang-(1-7) action is mediated by Mas, we used cardiomyocytes isolated from Mas-deficient mice. In Mas-deficient cardiomyocytes, Ang-(1-7) failed to increase NO levels. Moreover, Mas-ablation was accompanied by significant alterations in the proteins involved in the regulation of endothelial NO synthase activity, indicating that endothelial NO synthase and its binding partners are important effectors of the Mas-mediated pathway in cardiomyocytes. We then investigated the role of the Ang- (1-7) 
T he renin-angiotensin system plays a major role in the pathogenesis of cardiovascular diseases. 1 Although angiotensin (Ang) II is the major effector of this system, several other peptides are now recognized as being biologically important. Of particular importance is the heptapeptide Ang-(1-7). Accordingly, Ang-(1-7) has been reported to have a pivotal role in the regulation of the cardiovascular system. 2, 3 Briefly, this peptide decreased the incidence and duration of ischemia-reperfusion arrhythmias, 4 improved the postischemic contractile function in isolated perfused rat hearts, and prevented Ang II-induced cardiac remodeling. 5 Previously, we have reported that Ang-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. 6 In keeping with this finding, many of the cardiovascular effects of Ang-(1-7) can be completely blocked by the selective Mas antagonist A-779, 7 suggesting an important role for the Ang-(1-7)/Mas axis in the cardiovascular system. Supporting these findings, Mas-deficient (Mas Ϫ/Ϫ ) mice present reduced cardiac function characterized by decreased fractional shortening. 8 Overall, these studies indicate that interactions between Ang-(1-7) and Mas play an important role in cardiac function, and genetic deletion of Mas leads to cardiac impairment and endothelial dysfunction. 9 However, the cellular mechanism and signaling pathways involved in Ang-(1-7)/Mas actions in the cardiac cell are not defined. Recently, Sampaio et al 10 have demonstrated that Ang-(1-7) actions in endothelial cells cause endothelial NO synthase (eNOS) phosphorylation and result in NO release through the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt)-dependent pathway. Ang-(1-7) via Mas also reduce the overall growth of cardiomyocytes. 11 In this study, we investigated the involvement of the Ang-(1-7)/Mas axis in NO generation and Ca 2ϩ handling in adult ventricular myocytes.
Methods
For expanded Methods please see the data supplement available online at http://hyper.ahajournals.org.
Animals
Twenty-five wild-type (WT) and 22 Mas knockout (Mas Ϫ/Ϫ ) on FVB/N genetic background male mice (3 to 6 months old) were obtained from the transgenic animal facilities of the Federal University of Minas Gerais Laboratory of Hypertension. All of the experimental protocols conform to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by our institution.
Cardiomyocyte Isolation and Confocal Imaging
Freshly isolated ventricular myocytes were stored in DMEM (Sigma Aldrich) until they were used 12 (within 4 hours). Confocal images were obtained using the ZEISS Meta confocal microscope (Zeiss Germany) from CEMEL (Biological Sciences Institute, Federal University of Minas Gerais).
Results

Ang-(1-7) Increases NO Production in Ventricular Cardiomyocytes
To investigate whether Ang-(1-7) is able to generate NO in adult ventricular myocytes, we used the fluorescent indicator 4-amino-5methylamino-2Ј,7Ј-difluorofluorescein (DAF-FM) to monitor cellular NO generation. Cells were exposed to Ang-(1-7) for 15 minutes, and maximal DAF fluorescence was observed at 10 nmol/L ( Figure 1A) , showing a concentration-dependent increase on NO generation by Ang-(1-7) in cardiomyocytes. Figure 1B shows that Ang-(1-7)-dependent (10 nmol/L; 15 minutes) NO raise is abolished by the NO synthase inhibitor N G -nitro-L-arginine methyl ester (10 mol/L; 15 minutes). On the other hand, the inactive isomer N G -nitro-D-arginine methyl ester had no effect on Ang-(1-7)-induced NO raise, indicating that Ang-(1-7) stimulates NO generation in cardiomyocytes. To further confirm the specificity of the DAF probe, we incubated cardiomyocytes with the NO donor sodium nitroprusside ( Figure S1 ). Ang-(1-7)-induced NO generation presented a time dependence, as shown in Figure 1C , and significant NO generation occurred 5 minutes after Ang-(1-7) stimulation. LY294002, a PI3K inhibitor (10 mol/L), blocked the Ang-(1-7)-induced increase in NO fluorescence in cardiomyocytes, suggesting the involvement of the PI3K/Akt pathway in Ang-(1-7) effects in cardiomyocytes ( Figure 1D ). To confirm whether Ang-(1-7) stimulation in cardiomyocytes leads to Akt activation, we examined the time course of Akt phosphorylation in Ang-(1-7)-treated cells. As shown in Figure 1E , Akt phosphorylation induced by Ang-(1-7) increased significantly in a time-dependent manner. Both endothelial NO synthase (eNOS) and neuronal NO synthase participate in NO production in the heart. The fact that Ang-(1-7) via Akt mediates eNOS activation in endothelial cells prompted us to investigate whether Ang-(1-7) stimulation also results in eNOS activation in cardiomyocytes. eNOS activity is regulated through coordinated phosphorylation of specific sites. Phosphorylation of eNOS at Ser 1177 (stimulatory site) results in an increase in enzyme activity and NO production, whereas eNOS phosphorylation at Thr 495 (inhibitory site) reduces enzyme activity and NO production. As shown in Figure 1F , Ang-(1-7) induced eNOS Ser1177 phosphorylation in a time-dependent manner similar to the effects of Ang-(1-7) on Akt activation and NO generation. To verify whether Ang-(1-7) actions on ventricular myocytes occurred via Mas, cells were preincubated with the Mas antagonist A-779 (1 mol/L; 15 minutes) and then stimulated with Ang-(1-7) (10 nmol/L; 15 minutes). Figure 2A and 2B show that A-779 prevented the Ang-(1-7)-dependent increase in NO. Moreover, the changes in eNOS and Akt phosphorylation levels by Ang-(1-7) were also blocked by A-779 treatment ( Figure 2C through 2E).
Ang-(1-7)-Induced NO Generation Is Abolished in
To further investigate the role of Mas in Ang-(1-7)-dependent NO generation in cardiac cells, we used cardiomyocytes isolated from Mas Ϫ/Ϫ mice. Figure 3 shows that NO fluorescence failed to augment in Mas Ϫ/Ϫ cardiomyocytes treated with Ang-(1-7) (10 nmol/L; 15 minutes), supporting our findings presented in Figure 2 . As expected, the Mas antagonist A-779 had no effect on DAF fluorescence in Ang-(1- 
Mas Ablation Is Accompanied by Changes in Proteins Involved in the Regulation of eNOS Activity
In cardiomyocytes, eNOS is part of a macromolecular complex composed of caveolin-3, heat shock protein 90 (Hsp90), and Akt. Caveolin-3 has been shown to directly interact with eNOS and inhibits its basal activity by preventing calmodulin interaction. 13 Hsp90 acts as a scaffold protein to recruit Akt in the eNOS complex, thereby promoting eNOS phosphorylation-dependent activation. 14 The third component, Akt, phosphorylates eNOS at Ser 1177, rendering the enzyme active. 13 To investigate possible alterations in the proteins involved in 
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eNOS Thr/GAPDH . A significant increase in Akt phosphorylation level was observed after Ang-(1-7) treatment. C through E, GAPDH expression levels were used as a loading control. nϭnumber of cardiomyocyte homogenates. #PϽ0.05 vs control; *PϽ0.05.
the regulation of eNOS in Mas Ϫ/Ϫ cardiomyocytes, we performed Western blot analyses in protein homogenates from isolated cardiomyocytes. Immunoblots revealed similar eNOS protein levels in cardiomyocytes from Mas Ϫ/Ϫ mice when compared with control cells ( Figure 4A ). In contrast, Western blot analysis showed augmented expression of caveolin-3 (by 77%; Figure 4B ) in Mas Ϫ/Ϫ cardiomyocytes. We also observed a significant reduction in levels of Hsp90 in Mas Ϫ/Ϫ cardiomyocytes when compared with control cells ( Figure 4C ). We next evaluated Akt and Akt phosphorylation levels in these cells. Increased Akt levels were observed in Mas Ϫ/Ϫ cardiomyocytes (by Ϸ56%; Figure 4D ). This result was further confirmed by immunofluorescence techniques where cardiomyocytes from Mas Ϫ/Ϫ and WT mice were stained with specific antibodies against Akt. Confocal images in Figure 4E show increased Akt levels in Mas Ϫ/Ϫ cardiomyocytes. To verify Akt activation in Mas Ϫ/Ϫ cardiomyocytes, we assessed phosphorylated Akt levels in these cells. Although Akt expression was higher in Mas Ϫ/Ϫ cells, phosphorylated Akt levels were significantly reduced, suggesting that less active enzyme was found in Mas Ϫ/Ϫ cells when compared with control cardiomyocytes ( Figure 4F ). These data clearly show changes in expression levels of proteins involving the eNOS complex in Mas Ϫ/Ϫ cardiomyocytes. . D, Akt protein levels were significantly higher in Mas Ϫ/Ϫ cardiomyocytes, whereas phosphorylated Akt levels were lower in these cells (F). E, Immunofluorescence using an anti-Akt-specific antibody showed increased Akt expression (green) in Mas Ϫ/Ϫ cardiomyocytes. The nucleus is stained with 4Ј,6-diamidino-2-phenylindole (blue). Barϭ10 m. A through F, Top, Representative Western blots; bottom, averaged densitometry. GAPDH expression levels were used as a loading control. #PϽ0.05. n indicates the number of cardiomyocyte homogenates.
Increased Apoptosis in the Mas
؊/؊ Heart
Recently, evidence was presented that NO plays an important role in apoptotic cell death. 15, 16 There is evidence suggesting that high concentrations of NO produced from inducible NO synthase induce apoptosis, whereas low concentrations of NO produced from eNOS reduce apoptosis. 15 Given the potential protective effect triggered by eNOS activation in cardiac cells, 14 we hypothesized that Mas Ϫ/Ϫ hearts could exhibit a higher apoptosis rate, because these hearts present significant alterations in proteins involved in eNOS regulation. To investigate this issue, Mas Ϫ/Ϫ hearts were stained using a TUNEL assay, and the total fluorescence was quantified. Figure S2 shows that prominent apoptosis was evident in the left and right ventricles of Mas Ϫ/Ϫ mice when compared with WT hearts. Mean fluorescence levels were significantly higher in the ventricle of Mas Ϫ/Ϫ mice when compared with WT mice, suggesting that differences in apoptotic cell death contribute significantly to Mas Ϫ/Ϫ cardiac defects.
Ca
2؉ Signaling Defects in Mas ؊/؊ Cardiomyocytes
To investigate the role of the Ang-(1-7)/Mas axis on cardiomyocyte Ca 2ϩ dynamics, isolated cardiomyocytes were loaded with the Ca 2ϩ sensitive dye Fluo-4/AM, treated with Ang-(1-7) and visualized by confocal microscopy. Top panels of Figure S3A display representative line-scanning images recorded from electrically stimulated (at 1 Hz) cardiomyocytes treated or not with 10 nmol/L of Ang-(1-7) for 15 minutes. Figure S3B shows that acute Ang-(1-7) treatment failed to increase peak Ca 2ϩ transient in WT cardiomyocytes. In a similar way, Ang-(1-7) treatment did not alter Ca 2ϩ transient kinetics of decay ( Figure S3C) Figure  5A and 5B), and slower [Ca 2ϩ ] i transient kinetics of decay when compared with WT cardiomyocytes ( Figure 5C and 5D). These results were consistent with the depression of contractility that has been observed previously in Mas Ϫ/Ϫ hearts. 8 Figure 5E ). Reduced SERCA2a levels in Mas Ϫ/Ϫ cardiomyocytes can explain, at least in part, the changes in Ca 2ϩ handling observed in these cells.
Discussion
Recently, multiple lines of evidence have shown that the beneficial effects of Ang-(1-7) in the heart are mediated by Mas. However, the signaling pathways involved in these effects on ventricular myocytes are unknown. In this study, we have made several novel observations. First, we demon- 
Ang-(1-7)/Mas Signaling Pathways in Adult Ventricular Cardiomyocytes
Sampaio et al 10 have demonstrated that Ang-(1-7) actions in endothelial cells cause eNOS phosphorylation, resulting in NO release through the PI3K/Akt-dependent pathway. Here, we have shown direct evidence that eNOS and PI3K/Akt are downstream effectors in the Ang-(1-7) signaling pathway in ventricular myocytes. Multiple lines of investigation suggest that activation of the PI3K/Akt pathway is a critical determinant of cell survival and growth in a variety of signaling pathways. 17 Given the beneficial effects of Ang-(1-7) in the heart, it seems likely that activation of this pathway plays an important role in Ang-(1-7) cardioprotective effects.
Our data are in agreement with a recent observation by Giani et al 18 showing that Ang-(1-7) via Mas stimulates the phosphorylation of Akt in the heart; however, this previous study was performed using whole heart homogenates. By using isolated ventricular myocytes, we specifically addressed the downstream mediators involved in the Ang-(1-7) signaling pathway in the cardiac cell. Nevertheless, a variety of regulators have been identified that influence NO synthesis by regulation of eNOS phosphorylation, including kinases and phosphatases. 14 The lack of a significant effect of Ang-(1-7) on Ca 2ϩ handling in cardiomyocytes does not exclude the possibility that Ang-(1-7) might indirectly affect Ca 2ϩ handling protein function. It is well established that constitutive NO production modulates the function of various components of cardiomyocyte excitation-contraction coupling. 19 Martinez-Moreno et al 20 have shown that a fraction of the total eNOS protein directly associates with RyR2. In keeping with this finding, Petroff et al 21 suggested that eNOS-derived NO enhanced RyR2 open probability in cardiomyocytes in response to stretch. Moreover, there has been some evidence in the literature supporting an interplay among eNOS, cGMPdependent protein kinase, and Ca 2ϩ handling in cardiomyocytes. 22 Accordingly, insulin treatment of cardiomyocytes increased phosphorylation and activity of eNOS, leading to augmented phospholamban phosphorylation and consequent SERCA2a activation in reoxygenated cardiomyocytes. In this context, Ang-(1-7)-dependent NO could modulate the activity of multiple Ca 2ϩ handling proteins in the cell. On the other hand, it is possible that alterations in the proteins involving the eNOS complex and consequent reduction in eNOS activity in Mas Ϫ/Ϫ cardiomyocytes contribute to the Ca 2ϩ handling dysfunction observed in these cells and might be related to SERCA2a changes. This finding is particularly important because it shows for the first time that the Ang-(1-7)/ Mas axis is important for long-term maintenance of normal Ca 2ϩ handling in the cardiac cell. Nevertheless, we cannot exclude the possibility that a decreased level of SERCA2a is secondary to the cardiac dysfunction observed in Mas Ϫ/Ϫ hearts. Additional experiments are necessary to elucidate the relationship between the Ang-(1-7)-dependent NO signaling pathway and Ca 2ϩ handling in cardiomyocytes.
eNOS-Derived NO in Cardiomyocytes
Both eNOS and neuronal NO synthase participate in NO production in the heart. In this work, we showed direct evidence of eNOS as a downstream factor in the Ang-(1-7) signaling pathway in cardiomyocytes. Moreover, we showed that Ang-(1-7) increased NO production in cardiac cells in a time-dependent manner through the PI3K/Akt-dependent pathway. Although we cannot exclude a role of neuronal NO synthase in NO production in adult cardiomyocytes, we believe that, at least in part, we can attribute NO generated by Ang-(1-7) in adult cardiomyocytes to eNOS. Two sets of data support this finding: Ang-(1-7) treatment of cardiomyocytes leads to eNOS activation, and Mas-ablation leads to alterations in proteins involved in eNOS regulation in the cell. Although we did not observe changes in eNOS expression levels between Mas Ϫ/Ϫ and WT cardiomyocytes, we believe that eNOS activity in these cells is reduced (see below). Interestingly, Ang II type 2 receptor-deficient mice showed decreased cardiac eNOS expression. 23 The contribution of neuronal NO synthase to NO generation in control and Mas Ϫ/Ϫ cardiomyocytes awaits elucidation.
Reduced eNOS Activity in Mas ؊/؊ Cardiomyocytes
Several factors support the finding that eNOS activity is reduced in Mas Ϫ/Ϫ cardiomyocytes, the first being increased caveolin-3 expression and consequent eNOS inhibition. Garcia-Cardena et al 24 have shown that peptides corresponding to the scaffolding domain of caveolin-3 inhibit eNOS in cardiomyocytes. In keeping with this finding NO synthase activity is reduced in caveolin-3-overexpressing hearts. 25 Second, Mas Ϫ/Ϫ cardiomyocytes show reduced Hsp90 levels. Low levels of Hsp90 reduce Akt recruitment to the eNOS complex, thereby preventing eNOS-dependent Akt activation. Third, Mas Ϫ/Ϫ cardiomyocytes present reduced Akt activity because of reduced phospho-Akt levels in these cells. Together, these data reveal an important association between receptor Mas and the eNOS signaling complex in adult cardiomyocytes.
There is evidence in the literature suggesting a cardioprotective role of eNOS-derived NO. 26 Specifically, regulation of NO synthesis in the heart by eNOS represents a critical final common pathway to explain the benefit of several effective treatments for both acute myocardial ischemia and chronic congestive cardiac failure. 14 Thus, it is possible that the alterations in the proteins involving the eNOS complex and consequent reduction in eNOS activity contribute to the cardiac dysfunction in Mas Ϫ/Ϫ hearts, including the increased apoptosis rate. However, it should be noted that, in addition to the potential cardioprotective effect triggered by eNOS, previous studies also indicated a deleterious effect of eNOSderived NO during myocardial ischemia/reperfusion. 27
Perspectives
Ang-(1-7) has been reported to have a pivotal role in the regulation of the cardiovascular system. We now report that Ang-(1-7) via Mas activates the PI3K/Akt pathway and eNOS, leading to NO production in cardiomyocytes. These data suggest that eNOS and Akt are important downstream effectors of the Ang-(1-7)/Mas-mediated pathway in cardiomyocytes and possibly play important roles in Ang-(1-7) beneficial effects in the heart. Our data reveal a previously unknown signaling pathway involved in NO production dependent on the Ang-(1-7)/Mas axis in ventricular myocytes that plays an important role in the regulation of cardiomyocyte function. During the development of pathological conditions, dysregulation of the Ang-(1-7) signaling pathway may contribute to the ventricular dysfunction observed under these conditions. 
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MOLECULAR MECHANISMS INVOLVED
Western blot
Adult ventricular myocytes were homogenated and protein content was quantified. 40-60 µg of protein were separated by SDS-PAGE, and immunoblotted.
Measurement of eNOS and Akt phosphorylation were performed in Ang-(1-7) (10 nmol/L, 15 minutes) treated cardiomyocytes unless otherwise specified. Protein levels were expressed as a ratio of optical densities. GAPDH band was used as a control for any inaccuracies in the protein loading. 
